Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthonius de Boer

Showing results (81-90 of 308) with videos related to

Pageof 31
Sort By:
British Journal of Clinical Pharmacology|December 27, 2019
The development of a test battery to assess the hand-eye functions relevant in predicting easy and accurate tablet subdivision in older people: A pilot studyDiana van Riet-Nales, Linda Donkerbroek, Agnes Nicia, et al.
Plos One|October 23, 2015
Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsFariba Ahmadizar, N Charlotte Onland-Moret, Anthonius de Boer, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 19, 2014
Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settingsTalitha I Verhoef, William K Redekop, Fazila Hasrat, et al.
British Journal of Clinical Pharmacology|April 23, 2002
Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?Aukje K Mantel-Teeuwisse, Olaf H Klungel, W M Monique Verschuren, et al.
The Annals of Pharmacotherapy|December 31, 2002
Oral antithrombotic use among myocardial infarction patientsMenno E van der Elst, Nelly Cisneros-Gonzalez, Cornelis J de Blaey, et al.
Pharmacoepidemiology and Drug Safety|July 13, 2006
Discrepancies between medication records of anticoagulation clinics and pharmacy recordsTom Schalekamp, Carolien Smit, Johanna H H van Geest-Daalderop, et al.
Stroke|August 8, 2009
Risk of hip/femur fracture after stroke: a population-based case-control studySander Pouwels, Arief Lalmohamed, Bert Leufkens, et al.
Plos One|September 3, 2015
Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsFariba Ahmadizar, N Charlotte Onland-Moret, Anthonius de Boer, et al.
Annals of Epidemiology|May 4, 2015
Left truncation results in substantial bias of the relation between time-dependent exposures and adverse eventsChristijan M Hazelbag, Olaf H Klungel, Tjeerd P van Staa, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 15, 2018
Non-steroidal anti-inflammatory drugs and the risk of out-of-hospital cardiac arrest: a case-control studyMohammad Bakhriansyah, Patrick C Souverein, Olaf H Klungel, et al.
Pageof 31

Showing results (81-90 of 308) with videos related to

Sort By:
Pageof 31
British Journal of Clinical Pharmacology|December 27, 2019
The development of a test battery to assess the hand-eye functions relevant in predicting easy and accurate tablet subdivision in older people: A pilot studyDiana van Riet-Nales, Linda Donkerbroek, Agnes Nicia, et al.
Plos One|October 23, 2015
Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsFariba Ahmadizar, N Charlotte Onland-Moret, Anthonius de Boer, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 19, 2014
Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settingsTalitha I Verhoef, William K Redekop, Fazila Hasrat, et al.
British Journal of Clinical Pharmacology|April 23, 2002
Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?Aukje K Mantel-Teeuwisse, Olaf H Klungel, W M Monique Verschuren, et al.
The Annals of Pharmacotherapy|December 31, 2002
Oral antithrombotic use among myocardial infarction patientsMenno E van der Elst, Nelly Cisneros-Gonzalez, Cornelis J de Blaey, et al.
Pharmacoepidemiology and Drug Safety|July 13, 2006
Discrepancies between medication records of anticoagulation clinics and pharmacy recordsTom Schalekamp, Carolien Smit, Johanna H H van Geest-Daalderop, et al.
Stroke|August 8, 2009
Risk of hip/femur fracture after stroke: a population-based case-control studySander Pouwels, Arief Lalmohamed, Bert Leufkens, et al.
Plos One|September 3, 2015
Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsFariba Ahmadizar, N Charlotte Onland-Moret, Anthonius de Boer, et al.
Annals of Epidemiology|May 4, 2015
Left truncation results in substantial bias of the relation between time-dependent exposures and adverse eventsChristijan M Hazelbag, Olaf H Klungel, Tjeerd P van Staa, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 15, 2018
Non-steroidal anti-inflammatory drugs and the risk of out-of-hospital cardiac arrest: a case-control studyMohammad Bakhriansyah, Patrick C Souverein, Olaf H Klungel, et al.
Pageof 31